Next Article in Journal
Changes in Hematologic Lab Measures Observed in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors, Ravulizumab and Eculizumab: Real-World Evidence from a US Based EMR Network
Previous Article in Journal
Molecular Tumor Boards: The Next Step towards Precision Therapy in Cancer Care
 
 
Article

Article Versions Notes

Hematol. Rep. 2023, 15(2), 256-265; https://doi.org/10.3390/hematolrep15020026
Action Date Notes Link
article xml file uploaded 19 April 2023 13:08 CEST Original file -
article xml uploaded. 19 April 2023 13:08 CEST Update https://www.mdpi.com/2038-8330/15/2/26/xml
article pdf uploaded. 19 April 2023 13:08 CEST Version of Record https://www.mdpi.com/2038-8330/15/2/26/pdf
article supplementary file uploaded. 19 April 2023 13:08 CEST - https://www.mdpi.com/2038-8330/15/2/26#supplementary
article html file updated 19 April 2023 13:10 CEST Original file https://www.mdpi.com/2038-8330/15/2/26/html
Back to TopTop